UCB

CIMZIA

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

UCB

Cimzia HCPCS:

J0717

HCPCS Code Descriptor:

Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)

Category:

J Code

Cimzia NDCs:

50474-0710-81, 50474-0700-62, 50474-0710-79

Primary Type:

Immunology:Anti-TNF

Generic/Specialty Status:

Single-Source

Package Type:

Multiple

Route of Administration:

Subcutaneous

Cimzia CPT Codes:

Potential CPT administration codes for Cimzia can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Cimzia:

CIMZIA is an Immunology:Anti-TNF drug manufactured by UCB and administered via the Subcutaneous route of administration. The J Code: J0717 is aligned to the drug CIMZIA.

ACCESS PRICING AND MORE BY REGISTERING

J0717 Added Date:

January 1, 2014

J0717 Effective Date:

January 1, 2014

J0717 Termination Date:

HCPCS Active

Cimzia billing and coding information can be found through Ucb at the link below:
Cimzia patient assistance information can be found through UCBCARES at the URL: https://www.ucb-usa.com/Patients/Patients
CIMZIA prescribing information can be found at the link below:
Information regarding CIMZIA’s side effects can be found at MedlinePlus